The Asia Pacific Bioabsorbable Stents Market is expected to witness market growth of 8.2% CAGR during the forecast period (2021-2027).
Some of the driving factors of the bioabsorbable stents market are increasing aging population who are more prone to coronary and peripheral artery diseases, an increasing number of PCI procedures, rising focus of companies on clinical trials of bioresorbable stents, growing adoption of these stents by physicians and patients, and growing preferences of the patients for minimally invasive therapies. Along with these factors, the market of bioabsorbable stents is also fueled by the surge in occurrence of heart diseases along with surge in the geriatric population, increasing demand for the minimally invasive procedure, and increasing research & development activities in this domain.
Many new products in the Asia-Pacific market can assists cardiologists to be more accurate when inserting the stent which is essential components for safety and efficacy. The design, range of sizes, and higher flexibility mean physicians don’t have to utilize as much force when they insert an advanced stent as compared to other stents. Advancement in the domain of developing stents is bringing a high level of safety and new features that makes it possible for cardiologists to effectively perform complicated procedures that are now responsible for a major percentage of the cases.
According to the World Health Organization (WHO), it has been observed that the leading cause of death around the globe is cardiovascular disease. In addition to this, the WHO has evaluated that in 2016, around 17.9 million individuals died because of cardiovascular diseases (CVDs) which accounts for 31% of the total deaths worldwide, and 85% of these deaths were because of heart attacks and stroke. According to the reports of the Australian Heart Foundation, cardiovascular disease (CVD) is a leading cause of death across Australia, with a major portion of the death is due to CVD in Australia in 2017. Cardiovascular diseases are responsible for killing one Australian in every 12 minutes. Therefore, the growth of the global bioabsorbable stents is expected to be fuelled by the massive surge in the rate of CVD around the world.
The China market dominated the Asia Pacific Cardiac Center Market by Country in 2020, thereby, achieving a market value of $3.8 Million by 2027. The Japan market is showcasing a CAGR of 11.1% during (2021-2027). Additionally, The India market is poised to grow at a CAGR of 11.3% during (2021-2027).
Based on Biomaterial, the market is segmented into Polymeric and Metallic. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End User, the market is segmented into Hospital and Cardiac Center. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Terumo Corporation, Arterius Ltd., Elixir Medical Corporation, Amaranth Medical, Inc., and REVA Medical, LLC.
Scope of the Study
Market Segments covered in the Report:
By Biomaterial
By Application
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
Some of the driving factors of the bioabsorbable stents market are increasing aging population who are more prone to coronary and peripheral artery diseases, an increasing number of PCI procedures, rising focus of companies on clinical trials of bioresorbable stents, growing adoption of these stents by physicians and patients, and growing preferences of the patients for minimally invasive therapies. Along with these factors, the market of bioabsorbable stents is also fueled by the surge in occurrence of heart diseases along with surge in the geriatric population, increasing demand for the minimally invasive procedure, and increasing research & development activities in this domain.
Many new products in the Asia-Pacific market can assists cardiologists to be more accurate when inserting the stent which is essential components for safety and efficacy. The design, range of sizes, and higher flexibility mean physicians don’t have to utilize as much force when they insert an advanced stent as compared to other stents. Advancement in the domain of developing stents is bringing a high level of safety and new features that makes it possible for cardiologists to effectively perform complicated procedures that are now responsible for a major percentage of the cases.
According to the World Health Organization (WHO), it has been observed that the leading cause of death around the globe is cardiovascular disease. In addition to this, the WHO has evaluated that in 2016, around 17.9 million individuals died because of cardiovascular diseases (CVDs) which accounts for 31% of the total deaths worldwide, and 85% of these deaths were because of heart attacks and stroke. According to the reports of the Australian Heart Foundation, cardiovascular disease (CVD) is a leading cause of death across Australia, with a major portion of the death is due to CVD in Australia in 2017. Cardiovascular diseases are responsible for killing one Australian in every 12 minutes. Therefore, the growth of the global bioabsorbable stents is expected to be fuelled by the massive surge in the rate of CVD around the world.
The China market dominated the Asia Pacific Cardiac Center Market by Country in 2020, thereby, achieving a market value of $3.8 Million by 2027. The Japan market is showcasing a CAGR of 11.1% during (2021-2027). Additionally, The India market is poised to grow at a CAGR of 11.3% during (2021-2027).
Based on Biomaterial, the market is segmented into Polymeric and Metallic. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End User, the market is segmented into Hospital and Cardiac Center. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Terumo Corporation, Arterius Ltd., Elixir Medical Corporation, Amaranth Medical, Inc., and REVA Medical, LLC.
Scope of the Study
Market Segments covered in the Report:
By Biomaterial
- Polymeric
- Metallic
By Application
- Coronary Artery Disease
- Peripheral Artery Disease
By End User
- Hospital
- Cardiac Center
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Abbott Laboratories
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- Arterius Ltd.
- Elixir Medical Corporation
- Amaranth Medical, Inc.
- REVA Medical, LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Bioabsorbable Stents Market, by Biomaterial
1.4.2 Asia Pacific Bioabsorbable Stents Market, by Application
1.4.3 Asia Pacific Bioabsorbable Stents Market, by End User
1.4.4 Asia Pacific Bioabsorbable Stents Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Bioabsorbable Stents Market by Biomaterial
3.1 Asia Pacific Polymeric Market by Country
3.2 Asia Pacific Metallic Market by Country
Chapter 4. Asia Pacific Bioabsorbable Stents Market by Application
4.1 Asia Pacific Coronary Artery Disease Market by Country
4.2 Asia Pacific Peripheral Artery Disease Market by Country
Chapter 5. Asia Pacific Bioabsorbable Stents Market by End User
5.1 Asia Pacific Hospital Market by Country
5.2 Asia Pacific Cardiac Center Market by Country
Chapter 6. Asia Pacific Bioabsorbable Stents Market by Country
6.1 China Bioabsorbable Stents Market
6.1.1 China Bioabsorbable Stents Market by Biomaterial
6.1.2 China Bioabsorbable Stents Market by Application
6.1.3 China Bioabsorbable Stents Market by End User
6.2 Japan Bioabsorbable Stents Market
6.2.1 Japan Bioabsorbable Stents Market by Biomaterial
6.2.2 Japan Bioabsorbable Stents Market by Application
6.2.3 Japan Bioabsorbable Stents Market by End User
6.3 India Bioabsorbable Stents Market
6.3.1 India Bioabsorbable Stents Market by Biomaterial
6.3.2 India Bioabsorbable Stents Market by Application
6.3.3 India Bioabsorbable Stents Market by End User
6.4 South Korea Bioabsorbable Stents Market
6.4.1 South Korea Bioabsorbable Stents Market by Biomaterial
6.4.2 South Korea Bioabsorbable Stents Market by Application
6.4.3 South Korea Bioabsorbable Stents Market by End User
6.5 Singapore Bioabsorbable Stents Market
6.5.1 Singapore Bioabsorbable Stents Market by Biomaterial
6.5.2 Singapore Bioabsorbable Stents Market by Application
6.5.3 Singapore Bioabsorbable Stents Market by End User
6.6 Malaysia Bioabsorbable Stents Market
6.6.1 Malaysia Bioabsorbable Stents Market by Biomaterial
6.6.2 Malaysia Bioabsorbable Stents Market by Application
6.6.3 Malaysia Bioabsorbable Stents Market by End User
6.7 Rest of Asia Pacific Bioabsorbable Stents Market
6.7.1 Rest of Asia Pacific Bioabsorbable Stents Market by Biomaterial
6.7.2 Rest of Asia Pacific Bioabsorbable Stents Market by Application
6.8 Rest of Asia Pacific Bioabsorbable Stents Market by End User
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals & Trials:
7.1.5.2 Acquisition and Mergers:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 BIOTRONIK SE & Co. KG
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Approvals & Trials:
7.4 Boston Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 MicroPort Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Terumo Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.7 Arterius Ltd.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 Elixir Medical Corporation
7.8.1 Company Overview
7.9 Amaranth Medical, Inc.
7.9.1 Company Overview
7.10. REVA Medical, Inc.
7.10.1 Company OverviewList of Tables
Table 1 Asia Pacific Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 2 Asia Pacific Bioabsorbable Stents Market, 2021-2027, USD Million
Table 3 Asia Pacific Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 4 Asia Pacific Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 5 Asia Pacific Polymeric Market by Country, 2017 - 2020, USD Million
Table 6 Asia Pacific Polymeric Market by Country, 2021-2027, USD Million
Table 7 Asia Pacific Metallic Market by Country, 2017 - 2020, USD Million
Table 8 Asia Pacific Metallic Market by Country, 2021-2027, USD Million
Table 9 Asia Pacific Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 10 Asia Pacific Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 11 Asia Pacific Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
Table 12 Asia Pacific Coronary Artery Disease Market by Country, 2021-2027, USD Million
Table 13 Asia Pacific Peripheral Artery Disease Market by Country, 2017 - 2020, USD Million
Table 14 Asia Pacific Peripheral Artery Disease Market by Country, 2021-2027, USD Million
Table 15 Asia Pacific Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 16 Asia Pacific Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 17 Asia Pacific Hospital Market by Country, 2017 - 2020, USD Million
Table 18 Asia Pacific Hospital Market by Country, 2021-2027, USD Million
Table 19 Asia Pacific Cardiac Center Market by Country, 2017 - 2020, USD Million
Table 20 Asia Pacific Cardiac Center Market by Country, 2021-2027, USD Million
Table 21 Asia Pacific Bioabsorbable Stents Market by Country, 2017 - 2020, USD Million
Table 22 Asia Pacific Bioabsorbable Stents Market by Country, 2021-2027, USD Million
Table 23 China Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 24 China Bioabsorbable Stents Market, 2021-2027, USD Million
Table 25 China Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 26 China Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 27 China Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 28 China Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 29 China Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 30 China Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 31 Japan Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 32 Japan Bioabsorbable Stents Market, 2021-2027, USD Million
Table 33 Japan Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 34 Japan Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 35 Japan Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 36 Japan Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 37 Japan Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 38 Japan Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 39 India Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 40 India Bioabsorbable Stents Market, 2021-2027, USD Million
Table 41 India Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 42 India Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 43 India Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 44 India Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 45 India Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 46 India Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 47 South Korea Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 48 South Korea Bioabsorbable Stents Market, 2021-2027, USD Million
Table 49 South Korea Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 50 South Korea Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 51 South Korea Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 52 South Korea Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 53 South Korea Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 54 South Korea Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 55 Singapore Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 56 Singapore Bioabsorbable Stents Market, 2021-2027, USD Million
Table 57 Singapore Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 58 Singapore Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 59 Singapore Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 60 Singapore Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 61 Singapore Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 62 Singapore Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 63 Malaysia Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 64 Malaysia Bioabsorbable Stents Market, 2021-2027, USD Million
Table 65 Malaysia Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 66 Malaysia Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 67 Malaysia Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 68 Malaysia Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 69 Malaysia Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 70 Malaysia Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 71 Rest of Asia Pacific Bioabsorbable Stents Market, 2017 - 2020, USD Million
Table 72 Rest of Asia Pacific Bioabsorbable Stents Market, 2021-2027, USD Million
Table 73 Rest of Asia Pacific Bioabsorbable Stents Market by Biomaterial, 2017 - 2020, USD Million
Table 74 Rest of Asia Pacific Bioabsorbable Stents Market by Biomaterial, 2021-2027, USD Million
Table 75 Rest of Asia Pacific Bioabsorbable Stents Market by Application, 2017 - 2020, USD Million
Table 76 Rest of Asia Pacific Bioabsorbable Stents Market by Application, 2021-2027, USD Million
Table 77 Rest of Asia Pacific Bioabsorbable Stents Market by End User, 2017 - 2020, USD Million
Table 78 Rest of Asia Pacific Bioabsorbable Stents Market by End User, 2021-2027, USD Million
Table 79 Key Information - Abbott Laboratories
Table 80 key Information - B. Braun Melsungen AG
Table 81 Key Information - BIOTRONIK SE & Co. KG
Table 82 key Information - Boston Scientific Corporation
Table 83 key Information - MicroPort Scientific Corporation
Table 84 Key Information - Terumo Corporation
Table 85 key information - Arterius Ltd.
Table 86 key information - Elixir Medical Corporation
Table 87 key information - Amaranth Medical, Inc.
Table 88 key information - REVA Medical, LLC
List of Figures
Fig 1 Methodology for the research
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- Arterius Ltd.
- Elixir Medical Corporation
- Amaranth Medical, Inc.
- REVA Medical, LLC
Methodology
LOADING...
